Glycomics/Glycobiology Market Analysis By Product (Enzymes, Kits, Reagents, Instruments), By Application (Drug Discovery & Development, Diagnostics), By End-use, And Segment Forecasts, 2014 - 2025

Published: Apr, 2017 | Pages: 90 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)

The global glycomics/glycobiology market is expected to reach USD 2.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing investment in R&D by research institutes and pharmaceutical & biotechnology companies has been a major factor driving market growth. In addition, technological advancement has led to increased demand for advanced glycomics products for drug discovery & development, diagnostics, and oncology research. 

Escalating popularity of personalized medicines for the treatment of several severe chronic diseases and genetic disorders is another major factor contributing toward the growth. Personalized medicines involve the application of glycomics for the study of structure and function of glycans that are attached to biomolecules. Glycans play a crucial role in modulating various biological processes and their assessment can help determine the susceptibility to diseases & response to treatment. Thus, application of glycobiology products is expected to rise in near future, owing to their high potential in personalized medicine.

Untapped opportunities in developing regions, including Asia Pacific and Africa, are another major factor supporting the growth of the glycomics market. Glycomics research is important for comprehensive study of glycomes to understand the cellular signaling pathways, cell functions, genetic structure, and physiological & pathological aspects. Glycomics research has become more popular these days due to its advantages over genomic/proteomic analysis that cannot be used to study many pathological processes. Thus, the demand for advanced glycomics products by researchers and healthcare professionals is expected to fuel the sector growth.

Further key findings from the report suggest:

Enzymes segment is the fastest growing segment of the glycobiology market in 2016, due to its huge application in research & diagnostics and repetitive purchase of these products

In the application segment, drug discovery & development accounted for the largest revenue share in 2016, owing to the growing focus on novel drug development and demand for personalized medicines

The academic and research institutes dominated in terms of revenue in 2016, owing to the large focus on glycobiology research and proteomics study

The North America glycobiology market is the leading regional sector and expected to dominate the market during forecast period

Existence of large number of research laboratories, pharmaceutical companies, and biotechnology companies in North America region is the major reason for the high demand for glycobiology products in this region

The Asia Pacific glycobiology market is expected to grow at the highest growth rate during the forecast period

Some of the major players include Danaher; ProZyme; Shimadzu Corporation; Agilent Technologies; Bruker; Merck KGaA; Takara Bio, Inc.; New England Biolabs; ThermoFisher Scientific, Inc.; and Waters Corporation

 Table of Contents

Chapter 1 Research Methodology
                1.1 Country-Wise Market: Base Estimates
                1.2 Global Market: CAGR Calculation
                1.3 Region-Based Segment Share Calculation
                1.4 Research Scope & Assumptions
                1.5 List of Data Sources
                    1.5.1 Data for primary interviews, by sources
                    1.5.2 Data for primary interviews, by region
Chapter 2 Executive Summary
                2.1 Market Snapshot
Chapter 3 Glycomics/Glycobiology Market Variables, Trends & Scope
                3.1 Market Segmentation & Scope
                3.2 Market Driver Analysis
                    3.2.1 Increasing focus on glycomics and proteomics research
                    3.2.2 Increasing investment in R&D by research institutes and pharmaceutical & biotechnology companies
                    3.2.3 Technological advancements in glycomics instruments
                    3.2.4 Untapped opportunities in developing region
                3.3 Market Restraint Analysis
                    3.3.1 Stringent government policies and regulations
                3.4 Key Opportunities Prioritized
                    3.4.1 Key opportunities prioritized, by product
                    3.4.2 Key opportunities prioritized, by application
                    3.4.3 Key opportunities prioritized, by end use
                3.5 Glycomics/Glycobiology - SWOT Analysis, By Factor (political & legal, economic and technological)
                3.6 Industry Analysis - Porter's
                3.7 Glycomics/Glycobiology Market: Market Position Analysis
Chapter 4 Glycomics/Glycobiology: Product Estimates & Trend Analysis
                4.1 Glycomics/Glycobiology market: Product movement analysis
                4.2 Instruments
                    4.2.1 Instruments market, 2014 - 2025 (USD Million)
                    4.2.2 Mass spectrometers
                        4.2.2.1 Mass spectrometers market, 2014 - 2025 (USD Million)
                    4.2.3 HPLC
                        4.2.3.1 HPLC market, 2014 - 2025 (USD Million)
                    4.2.4 MALDI-TOF mass spectrometers
                        4.2.4.1 MALDI-TOF mass spectrometers market, 2014 - 2025 (USD Million)
                    4.2.5 Array systems
                        4.2.5.1 Array systems market, 2014 - 2025 (USD Million)
                    4.2.6 Other instruments
                        4.2.6.1 Other instruments market, 2014 - 2025 (USD Million)
                4.3 Reagents
                    4.3.1 Reagents market, 2014 - 2025 (USD Million)
                    4.3.2 Glycoproteins
                        4.3.2.1 Glycoproteins market, 2014 - 2025 (USD Million)
                    4.3.3 Monosaccharides
                        4.3.3.1 Monosaccharides market, 2014 - 2025 (USD Million)
                    4.3.4 Oligosaccharides
                        4.3.4.1 Oligosaccharides market, 2014 - 2025 (USD Million)
                    4.3.5 Other reagents
                        4.3.5.1 Other reagents market, 2014 - 2025 (USD Million)
                4.4 Kits
                    4.4.1 Kits market, 2014 - 2025 (USD Million)
                    4.4.2 Glycan labeling kits
                        4.4.2.1 Glycan labeling kits market, 2014 - 2025 (USD Million)
                    4.4.3 Glycan purification kits
                        4.4.3.1 Glycan purification kits market, 2014 - 2025 (USD Million)
                    4.4.4 Glycan release kits
                        4.4.4.1 Glycan release kits market, 2014 - 2025 (USD Million)
                    4.4.5 Other kits
                        4.4.5.1 Other kits market, 2014 - 2025 (USD Million)
                4.5 Enzymes
                    4.5.1 Enzymes market, 2014 - 2025 (USD Million)
                    4.5.2 Glycosidases
                        4.5.2.1 Glycosidases market, 2014 - 2025 (USD Million)
                    4.5.3 Glycosyltransferases
                        4.5.3.1 Glycosyltransferases market, 2014 - 2025 (USD Million)
                    4.5.4 Neuraminidases
                        4.5.4.1 Neuraminidases market, 2014 - 2025 (USD Million)
                    4.5.5 Sialyltransferases
                        4.5.5.1 Sialyltransferases market, 2014 - 2025 (USD Million)
                    4.5.6 Other enzymes
                        4.5.6.1 Other enzymes market, 2014 - 2025 (USD Million)
Chapter 5 Glycomics/Glycobiology: Application Estimates & Trend Analysis
                5.1 Glycomics/Glycobiology Market: Application Movement Analysis
                5.2 Drug Discovery & Development
                    5.2.1 Drug discovery & development Market, 2014 - 2025 (USD Million)
                5.3 Diagnostics
                    5.3.1 Diagnostics Market, 2014 - 2025 (USD Million)
                5.4 Other Application
                    5.4.1 Other application Market, 2014 - 2025 (USD Million)
Chapter 6 Glycomics/Glycobiology: End-use Estimates & Trend Analysis
                6.1 Glycomics/Glycobiology Market: End-Use Movement Analysis
                6.2 Academic & Research Institutes
                    6.2.1 Academic & research institutes market, 2014 - 2025 (USD Million)
                6.3 Pharmaceutical & Biotechnology Companies
                    6.3.1 Pharmaceutical & biotechnology companies market, 2014 - 2025 (USD Million)
                6.4 CROs
                    6.4.1 CROs market, 2014 - 2025 (USD Million)
Chapter 7 Glycomics/Glycobiology: Regional Estimates & Trend Analysis, by Product, Application, End-use
                7.1 Glycomics/Glycobiology Market Share By Region, 2016 & 2025
                7.2 North America
                    7.2.1 North America glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                    7.2.2 North America glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                    7.2.3 North America glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                    7.2.4 U.S.
                        7.2.4.1 U.S. glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                        7.2.4.2 U.S. glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                        7.2.4.3 U.S. glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                    7.2.5 Canada
                        7.2.5.1 Canada glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                        7.2.5.2 Canada glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                        7.2.5.3 Canada glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                7.3 Europe
                    7.3.1 Europe glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                    7.3.2 Europe glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                    7.3.3 Europe glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                    7.3.4 Germany
                        7.3.4.1 Germany glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                        7.3.4.2 Germany glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                        7.3.4.3 Germany glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                    7.3.5 UK
                        7.3.5.1 UK glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                        7.3.5.2 UK glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                        7.3.5.3 UK glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                7.4 Asia Pacific
                    7.4.1 Asia Pacific glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                    7.4.2 Asia Pacific glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                    7.4.3 Asia Pacific glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                    7.4.4 Japan
                        7.4.4.1 Japan glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                        7.4.4.2 Japan glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                        7.4.4.3 Japan glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                    7.4.5 China
                        7.4.5.1 China glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                        7.4.5.2 China glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                        7.4.5.3 China glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                    7.4.6 India
                        7.4.6.1 India glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                        7.4.6.2 India glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                        7.4.6.3 India glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                7.5 Latin America
                        7.5.1.1 Latin America glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                        7.5.1.2 Latin America glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                        7.5.1.3 Latin America glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                    7.5.2 Brazil
                        7.5.2.1 Brazil glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                        7.5.2.2 Brazil glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                        7.5.2.3 Brazil glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                    7.5.3 Mexico
                        7.5.3.1 Mexico glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                        7.5.3.2 Mexico glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                        7.5.3.3 Mexico glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                7.6 MEA
                    7.6.1 MEA glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                    7.6.2 MEA glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                    7.6.3 MEA glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
                    7.6.4 South Africa
                        7.6.4.1 South Africa glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
                        7.6.4.2 South Africa glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
                        7.6.4.3 South Africa glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
Chapter 8 Competitive Landscape
                8.1 Strategy Framework
                8.2 Company Profiles
                    8.2.1 Danaher
                        8.2.1.1 Company overview
                        8.2.1.2 Financial performance
                        8.2.1.3 Product benchmarking
                        8.2.1.4 Strategic initiatives
                    8.2.2 Agilent Technologies
                        8.2.2.1 Company overview
                        8.2.2.2 Financial performance
                        8.2.2.3 Product benchmarking
                        8.2.2.4 Strategic initiatives
                    8.2.3 Thermo Fisher Scientific, Inc.
                        8.2.3.1 Company overview
                        8.2.3.2 Financial performance
                        8.2.3.3 Product benchmarking
                        8.2.3.4 Strategic initiatives
                    8.2.4 ProZyme
                        8.2.4.1 Company overview
                        8.2.4.2 Financial performance
                        8.2.4.3 Product benchmarking
                        8.2.4.4 Strategic initiatives
                    8.2.5 Shimadzu Corporation
                        8.2.5.1 Company overview
                        8.2.5.2 Financial performance
                        8.2.5.3 Product benchmarking
                        8.2.5.4 Strategic initiatives
                    8.2.6 Bruker
                        8.2.6.1 Company overview
                        8.2.6.2 Financial performance
                        8.2.6.3 Product benchmarking
                        8.2.6.4 Strategic initiatives
                    8.2.7 Merck KGaA
                        8.2.7.1 Company overview
                        8.2.7.2 Financial performance
                        8.2.7.3 Product benchmarking
                        8.2.7.4 Strategic initiatives
                    8.2.8 Takara Bio, Inc.
                        8.2.8.1 Company overview
                        8.2.8.2 Financial performance
                        8.2.8.3 Product benchmarking
                        8.2.8.4 Strategic initiatives
                    8.2.9 New England Biolabs
                        8.2.9.1 Company overview
                        8.2.9.2 Financial performance
                        8.2.9.3 Product benchmarking
                        8.2.9.4 Strategic initiatives
                    8.2.10 Waters Corporation
                        8.2.10.1 Company overview
                        8.2.10.2 Financial performance
                        8.2.10.3 Product benchmarking
                        8.2.10.4 Strategic initiatives

List of Tables

TABLE 1 Factors used in segment share estimation
TABLE 2 List of secondary data sources
TABLE 3 Primary interview details, by source
TABLE 4 Primary interview details, by region
TABLE 5 North America glycomics/glycobiology market, by country, 2014 - 2025 (USD Million)
TABLE 6 North America glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 7 North America glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 8 North America glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 9 U.S. glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 10 U.S. glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 11 U.S. glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 12 Canada glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 13 Canada glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 14 Canada glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 15 Europe glycomics/glycobiology market, by country, 2014 - 2025 (USD Million)
TABLE 16 Europe glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 17 Europe glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 18 Europe glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 19 Germany glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 20 Germany glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 21 Germany glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 22 UK glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 23 UK glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 24 UK glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 25 Asia Pacific glycomics/glycobiology market, by country, 2014 - 2025 (USD Million)
TABLE 26 Asia Pacific glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 27 Asia Pacific glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 28 Asia Pacific glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 29 Japan glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 30 Japan glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 31 Japan glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 32 China glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 33 China glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 34 China glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 35 India glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 36 India glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 37 India glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 38 Latin America glycomics/glycobiology market, by country, 2014 - 2025 (USD Million)
TABLE 39 Latin America glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 40 Latin America glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 41 Latin America glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 42 Brazil glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 43 Brazil glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 44 Brazil glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 45 Mexico glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 46 Mexico glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 47 Mexico glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 48 MEA glycomics/glycobiology market, by country, 2014 - 2025 (USD Million)
TABLE 49 MEA glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 50 MEA glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 51 MEA glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)
TABLE 52 South Africa glycomics/glycobiology market, by product, 2014 - 2025 (USD Million)
TABLE 53 South Africa glycomics/glycobiology market, by application, 2014 - 2025 (USD Million)
TABLE 54 South Africa glycomics/glycobiology market, by end use, 2014 - 2025 (USD Million)